Correlation of Zinc Turbidity Test and Globulins as revealed by Scan alterations in the y-globulin fraction and of the 27 with positive zinc turbidity tests, 20 had normal y-globulins and 7 abnormal y-globulins as indicated by the scan (Table V) .
Discussion. 'It would appear that although the total serum-protein estimation will reveal most cases in which alterations in the protein fractions may occur, some 10% of patients may have a normal total protein and abnormal distribution of fractions. Whilst an abnormal zinc turbidity is most likely to be associated with an abnormal total protein.vapproximately 75 % of normal zinc turbidities may be associated with abnormal total proteins. An abnormal zinc turbidity may be associated with a normal protein scan in 52 % of cases and specifically with a normal y-globulin in 74 %of cases, demonstrating that other factors must influence zinc turbidity. In 12%of patients with a normal zinc turbidity an abnormality may be found in y-globulin on scanning.
It would appear essential when selecting sera for electrophoretic scanning not to rely only on the zinc turbidity or the total protein as an indicator for carrying out the scan but to assess both together. The naked eye appearance of the strip is of course subjective but was found valuable as a general appreciation of the fractions present. The clinical diagnosis is only of value forincluding sera for scanning never to eliminate a serum from this procedure. The aims of this communication are, firstly, to review essential requirements in hormone assay procedures, secondly, to discuss the advantages and limitations of some of the methods which have been proposed for the estimation of individual anterior pituitary hormones and, finally, to attempt to indicate which, if any, of these techniques are, or are likely to become, suitable for use by clinical biochemists. Consideration will be given in turn to the pituitary gonadotrophic hormones -follicle-stimulating hormone (FSH) and luteinising hormone (LH), human growth hormone (HGH), adrenocorticotrophic hormone (ACTH) and thyroid-stimulating hormone (TSH).
For the estimation of FSH in clinical practice the method of choice is probably that depending on ovarian weight increase in mice treated with human chorionic gonadotrophin-the so-called 'ovarian augmentation test.' This technique is precise, specific and sufficiently sensitive to measure the small amounts of the hormone present in human body fluids. A large number of methods for the quantitative determination of LH are available including those depending on ventral prostatic weight and ovarian ascorbic acid and cholesterol depletion in rats; none of these procedures is suitable for routine clinical use. The mouse uterus test, which measures a mixture of FSH and LH activities, has been widely employed in patients and provides a a satisfactory index of anterior pituitary activity in health and disease. Its use by clinical biochemists is to be recommended provided a satisfactory animal colony is available.
For the estimation of HGH in plasma the method of choice at present is the radio-immuno-7 logical procedure of Hunter and Greenwood (1964) . This technique is considerably more sensitive than previously described biological procedures and once it has been established a large number of determinations can be made simultaneously. The main disadvantage of the method from the point of view of the clinical biochemist is the high initial cost of the equipment required.
For ACTH and TSH none of the methods at present available are suitable for routine clinical use. It is to be hoped that in the future satisfactory radio-immunological assays will be developed which will widen the sphere of applicability of estimations of these hormones. 
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At the present time gonadotrophin assays are generally conducted in urine rather than in blood and all results should be expressed in terms of a standard preparation. In the majority of studies reported in the literature specific assay methods for follicle-stimulating (FSH) and luteinising hormones (LH) have not been employed. Most of the results have been obtained by the test depending on the enlargement of the uterus in the intact immature mouse. This procedure is thought not to be specific for either FSH or LH and is claimed to measure 'total gonadotrophic activity.'
Using the mouse uterus test normal levels of human pituitary gonadotrophins (HPG) in urine have been established for adult males, women during reproductive life and postmenopausal women. In children, levels are often too low to be detected. Excretion patterns of FSH and LH have been found to vary considerably between individual subjects when assays are conducted during the normal menstrual cycle. If the mouse uterus test is employed high levels of urinary HPG are sometimes but not always found at mid-cycle.
Gonadotrophin assays in urine have been conducted in a wide variety of clinical states. In many of these such estimations have proved to be of little or no diagnostic or prognostic value. At present HPG assays are useful in the diagnosis of pituitary, ovarian or testicular failure with particular reference to patients suffering from primary or secondary amenorrhea. Little or no data are available on FSH and LH levels in these conditions. Gonadotrophin assays by the mouse uterus test have also proved to be of value in assessing the effectiveness of ovarian irradiation and the completeness of hypophysectomy.
The Assessment of ACTH Production J. G. SPRUNT
DUNDEE
The measurement of plasma ACTH is the most direct method of assessing ACTH production, but until now this has meant bioassay, which is expensive and time consuming. Using the bioassay, Ney et al, (1963) has established that plasma ACTH levels are about 0'1 to 0·59 mU/IOOmi. Raised levels are found in Cushing's syndrome following bilateral adrenalectomy and
